Hypertensive Heart Disease
📧 Sign up to get email alerts when something new happens for Hypertensive Heart Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Effectiveness of Valsartan Alone vs Combination Therapy in Hypertensive Heart Disease [Phase 1]
This Phase 1 trial compares valsartan alone versus a combination therapy regimen in hypertensive heart disease to assess relative effectiven…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline [NA]
This clinical trial update reports that the IPROACTIF program evaluating preservation of functioning and prevention of cognitive decline has…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Role of ARNi in Ventricular Remodeling in Hypertensive LVH [Phase 2]
A Phase 2 trial evaluating whether an angiotensin receptor-neprilysin inhibitor can influence ventricular remodeling in patients with hypert…
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Physiological Effects of Grape Seed Extract in Diastolic Heart Failure [Phase 1]
A Phase 1 trial from the University of Michigan evaluating the physiological effects of grape seed extract in diastolic heart failure and re…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Asian American Partnerships in Research and Empowerment (AsPIRE) [NA]
This entry reports the completion of the Asian American Partnerships in Research and Empowerment (AsPIRE) clinical trial sponsored by NYU La…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-05-05Clinical Trial Update: Irbesartan and Atenolol in Hypertensive Heart Disease [Phase 2, Phase 3]
Phase 2/3 trial evaluating irbesartan and atenolol in hypertensive heart disease has completed, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2012-07-10Clinical Trial Update: Importance of Aldosterone in the Pathogenesis of Hypertensive Heart Disease [Phase 3]
Phase 3 trial investigating the role of aldosterone in hypertensive heart disease has completed, examining aldosterone’s involvement in the …